Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther A Balogh

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Dermatological Treatment|December 23, 2020
Treating a chronic disease without chronic adherenceVarun Ranpariya, Esther A Balogh, Steven R Feldman
The Journal of Dermatological Treatment|March 13, 2020
Balancing rules with common sense in the protection of human subjectsSteven A Svoboda, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|November 17, 2020
An update on the impact of depression on the treatment of psoriasisKatheryn A Bell, Esther A Balogh, Steven R Feldman
Dermatology Online Journal|November 10, 2021
Morgellons disease etiology and therapeutic approach: a systematic reviewKatherine G Beuerlein, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|January 25, 2022
Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspectiveEsther A Balogh, Katherine G Beuerlein, Steven R Feldman
Expert Opinion on Drug Safety|February 18, 2020
Medications in dermatology are safer and more efficient than they used to beBritney N Wilson, Esther A Balogh, Steven R Feldman
The Annals of Pharmacotherapy|February 5, 2021
Clascoterone: How the Novel Androgen Receptor Inhibitor Fits Into the Acne Treatment ParadigmCaitlin G Purvis, Esther A Balogh, Steven R Feldman
The Journal of Dermatological Treatment|April 9, 2020
SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19Esther A Balogh, Courtney Heron, Steven R Feldman, et al.
American Journal of Clinical Dermatology|November 10, 2020
Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity DetectionCourtney E Heron, Rima I Ghamrawi, Esther A Balogh, et al.
The Journal of Dermatological Treatment|August 11, 2020
Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registriesMary Beth Gadarowski, Esther A Balogh, Arjun M Bashyam, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Dermatological Treatment|December 23, 2020
Treating a chronic disease without chronic adherenceVarun Ranpariya, Esther A Balogh, Steven R Feldman
The Journal of Dermatological Treatment|March 13, 2020
Balancing rules with common sense in the protection of human subjectsSteven A Svoboda, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|November 17, 2020
An update on the impact of depression on the treatment of psoriasisKatheryn A Bell, Esther A Balogh, Steven R Feldman
Dermatology Online Journal|November 10, 2021
Morgellons disease etiology and therapeutic approach: a systematic reviewKatherine G Beuerlein, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|January 25, 2022
Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspectiveEsther A Balogh, Katherine G Beuerlein, Steven R Feldman
Expert Opinion on Drug Safety|February 18, 2020
Medications in dermatology are safer and more efficient than they used to beBritney N Wilson, Esther A Balogh, Steven R Feldman
The Annals of Pharmacotherapy|February 5, 2021
Clascoterone: How the Novel Androgen Receptor Inhibitor Fits Into the Acne Treatment ParadigmCaitlin G Purvis, Esther A Balogh, Steven R Feldman
The Journal of Dermatological Treatment|April 9, 2020
SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19Esther A Balogh, Courtney Heron, Steven R Feldman, et al.
American Journal of Clinical Dermatology|November 10, 2020
Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity DetectionCourtney E Heron, Rima I Ghamrawi, Esther A Balogh, et al.
The Journal of Dermatological Treatment|August 11, 2020
Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registriesMary Beth Gadarowski, Esther A Balogh, Arjun M Bashyam, et al.
Pageof 4